Development of GHRH antagonist as therapy for Alzheimer's Disease Grant

Development of GHRH antagonist as therapy for Alzheimer's Disease .

date/time interval

  • April 1, 2017 - December 31, 2020

awarded by

administered by

sponsor award ID

  • Agreement

contributor